Capital International Investors
VTYX

Capital International Investors’s Ventyx Biosciences VTYX Stock Holding History

Capital International Investors’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,247,646
Closed -$12.1M – 455
2024
Q2 		$12.1M Buy
5,247,646
+2,893,497
+123% +$12M ﹤0.01% 391
2024
Q1 		$12.9M Hold
2,354,149
– – ﹤0.01% 390
2023
Q4 		$5.81M Sell
2,354,149
-373,703
-14% -$3.55M ﹤0.01% 408
2023
Q3 		$94.7M Hold
2,727,852
– – 0.02% 277
2023
Q2 		$89.5M Buy
2,727,852
+350,068
+15% +$12.1M 0.02% 295
2023
Q1 		$79.7M Buy
2,377,784
+263,040
+12% +$10.2M 0.02% 311
2022
Q4 		$69.3M Buy
+2,114,744
New +$62.6M 0.02% 310

Other funds holding VTYX

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital International Investors's VTYX Position: Q3 2024 in Review

Capital International Investors sold out of Ventyx Biosciences (VTYX) in Q3 2024, closing a stake of 5,247,646 shares — an estimated $12.1M sold.

Capital International Investors first reported a position in VTYX in Q4 2022 and held it in 7 quarters. The position peaked at $94.7M in Q3 2023. 118 funds tracked by Wall St. Rank hold VTYX as of Q3 2024.

  • Capital International Investors reported no remaining Ventyx Biosciences position as of Q3 2024 after selling out during the quarter.
  • Capital International Investors sold 5,247,646 Ventyx Biosciences shares in Q3 2024, an estimated $12.1M.
  • Capital International Investors first reported a position in Ventyx Biosciences in Q4 2022 and held it in 7 quarters.
  • Capital International Investors's Ventyx Biosciences position peaked at $94.7M in Q3 2023.
  • 118 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q3 2024.

Based on Capital International Investors's 13F filing for Q3 2024, filed 13 Nov 2024.